Figure 6.
Matrix PGs have different effects on the contraction of engineered collagen microtissues. (A,B) Representative light microscopy images of PDMS cantilever displacement in µTUGs. (C) SHG imaging of µTUGs made using collagen and NIH 3T3 fibroblasts. (D) Quantification of increased displacement observed with inclusion of 0.1 mg/ml versican (Ver) in 1.5 mg/ml collagen (Col) microtissue. (E) Quantification of the displacement observed in collagen microtissues with or without aggrecan (Agg; 0.1 mg/ml), decorin (Dec; 0.1 mg/ml), or lumican (Lum; 0.01 mg/ml or 0.05 mg/ml). N > 30 microtissues per each platform, three independent experiments (platforms) per condition. Points represent mean per platform. Scale bar = 200 µm. Data represent mean ± SE. *P < 0.05 and **P < 0.01.